» Articles » PMID: 3153064

Renal Tubular Hyperkalaemia in Childhood

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1988 Oct 1
PMID 3153064
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Potassium output from the body is regulated by renal excretion, which takes place predominantly in the late distal and cortical collecting tubules. The accepted model for potassium secretion implies the accumulation of potassium into the cell by the activity of basolateral Na-K-ATPase and its exit through voltage-dependent conductive channels. The factors regulating renal potassium secretion are potassium intake, distal urinary flow, systemic acid-base equilibrium, aldosterone, antidiuretic hormone and, probably, epinephrine. Renal handling of potassium is best studied by the response to the acute administration of furosemide. This loop diuretic not only increases sodium and chloride excretion but also enhances potassium and hydrogen ion excretion and stimulates the renin-aldosterone axis. The term "renal tubular hyperkalaemia" refers to a tubular dysfunction where the hyperkalaemia is disproportionate to any reduction in glomerular filtration rate (GFR) and not due primarily or solely to aldosterone deficiency or to drugs impairing either mineralocorticoid action or tubular transport. The syndromes of renal tubular hyperkalaemia mainly observed in childhood are "chloride shunt" syndrome, hyporeninaemic hypoaldosteronism and primary or secondary pseudohypoaldosteronism. Differential diagnosis between these conditions is easily made if attention is paid to the level of GFR, presence of sodium wasting, activity of the renin-aldosterone axis and renal response to acute administration of furosemide.

Citing Articles

Clinical and laboratory approaches in the diagnosis of renal tubular acidosis.

Santos F, Ordonez F, Claramunt-Taberner D, Gil-Pena H Pediatr Nephrol. 2015; 30(12):2099-107.

PMID: 25823989 DOI: 10.1007/s00467-015-3083-9.


Furosemide test in stage III-chronic kidney disease and kidney transplant patients on tacrolimus.

Musso C, Navarro M, Mombelli C, Giordani C, Groppa R, Martinez B Int Urol Nephrol. 2012; 45(5):1471-4.

PMID: 23233031 DOI: 10.1007/s11255-012-0351-5.


Monogenic forms of hypertension.

Simonetti G, Mohaupt M, Bianchetti M Eur J Pediatr. 2011; 171(10):1433-9.

PMID: 21404100 DOI: 10.1007/s00431-011-1440-7.


Fractional excretion of K, Na and Cl following furosemide infusion in healthy, young and very old people.

Musso C, Reynaldi J, Vilas M, De Miguel R, Imperiali N, Algranati L Int Urol Nephrol. 2009; 42(1):273-7.

PMID: 19277890 DOI: 10.1007/s11255-009-9547-8.


Investigation of hypertension and the recognition of monogenic hypertension.

Milford D Arch Dis Child. 1999; 81(5):452-5.

PMID: 10577368 PMC: 1718129. DOI: 10.1136/adc.81.5.452.


References
1.
Blachar Y, Kaplan B, GRIFFEL B, Levin S . Pseudohypoaldosteronism. Clin Nephrol. 1979; 11(6):281-8. View

2.
West M, Bendz O, Chen C, Singer G, Richardson R, Sonnenberg H . Development of a test to evaluate the transtubular potassium concentration gradient in the cortical collecting duct in vivo. Miner Electrolyte Metab. 1986; 12(4):226-33. View

3.
Sebastian A, Schambelan M, Sutton J . Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis. Am J Nephrol. 1984; 4(5):287-300. DOI: 10.1159/000166827. View

4.
Unal D, Picon G, Rouault F, MONTFORT G, Lebreuil G . [Hyponatremia with urinary sodium loss in newborn and older infants]. Pediatrie. 1975; 30(7):729-37. View

5.
Hudson J, CHOBANIAN A, RELMAN A . Hypoaldosteronism; a clinical study of a patient with an isolated adrenal mineralocorticoid deficiency, resulting in hyperkalemia and Stokes-Adams attacks. N Engl J Med. 1957; 257(12):529-36. DOI: 10.1056/NEJM195709192571201. View